CNBX Pharmaceuticals Inc. (CNBX) Operating Margin (2016 - 2024)

CNBX Pharmaceuticals' (CNBX) quarterly Operating Margin came in at 507.98% in Q1 2024, down 164.29% on a QoQ basis from 192.2% in Q4 2023.

CNBX Pharmaceuticals Inc. (CNBX) Operating Margin (2016 - 2024) Analysis & Trends

CNBX Pharmaceuticals (CNBX) has 8 years of Operating Margin data on file, last reported at 507.98% in Q1 2024.

Quarterly Operating Margin changed N/A year-over-year to 507.98% in Q1 2024, while the trailing twelve-month figure through Nov 2024 was 1102.63% (down 95121.0% YoY) and the FY2024 annual result came in at 448.31%, down 22124.0% from the prior year.
Operating Margin slipped to 507.98% in Q1 2024, from 192.2% in the prior quarter.
In the past five years, Operating Margin ranged from a high of 55.8% in Q2 2023 to a low of 66134.96% in Q1 2020.
A 4-year average of 16956.51% and a median of 1052.36% in 2024 frame the typical range for Operating Margin.
The widest YoY moves for Operating Margin: up 1721654 bps in 2020, down 2751225 bps in 2020.
Tracing CNBX's Operating Margin over 4 years: stood at 30390.26% in 2020, then soared by 95 bps to 1596.75% in 2022, then soared by 88 bps to 192.2% in 2023, then plunged by 164 bps to 507.98% in 2024.
The last three Operating Margin figures came in at 507.98% (Q1 2024), 192.2% (Q4 2023), and 161.5% (Q3 2023), per Business Quant data.

Download Data